Trials / Sponsors / Fenix Innovation Group
Fenix Innovation Group
Industry · 7 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | NTI164 in Autism Spectrum Disorder Autism, Autism Spectrum Disorder, Autism Disorder | Phase 3 | 2026-07-01 |
| Not Yet Recruiting | Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome RETT Syndrome With Proven MECP2 Mutation, Rett Syndrome | Phase 2 / Phase 3 | 2026-07-01 |
| Active Not Recruiting | NTI164 Human PK Study Healthy, Healthy Volunteer | Phase 1 | 2024-02-01 |
| Active Not Recruiting | Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Rett Syndrome | Phase 1 / Phase 2 | 2023-09-20 |
| Active Not Recruiting | Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric A PANS Pediatric Acute-Onset Neuropsychiatric Syndrome | Phase 1 / Phase 2 | 2023-06-02 |
| Unknown | Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder Autism Spectrum Disorder | Phase 2 / Phase 3 | 2022-11-30 |
| Unknown | Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Di Autism Spectrum Disorder | Phase 1 / Phase 2 | 2021-04-01 |